Glatiramer acetate after mitoxantrone induction improves MRI markers of lesion volume and permanent tissue injury in MS.
about
Glatiramer acetate for multiple sclerosisChemotherapeutics in the treatment of multiple sclerosis.CME/CNE Article: A Framework of Care in Multiple Sclerosis, Part 1: Updated Disease Classification and Disease-Modifying Therapy Use in Specific Circumstances.Update on the treatment options for multiple sclerosis.Glatiramer acetate and the glatiramoid class of immunomodulator drugs in multiple sclerosis: an update.Immunomodulatory drug treatment in multiple sclerosis.Managing MS in a changing treatment landscape.Glatiramer acetate for treatment of relapsing-remitting multiple sclerosis.Glatiramer acetate: a review of its use in patients with relapsing-remitting multiple sclerosis and in delaying the onset of clinically definite multiple sclerosis.Multiple sclerosis and the role of immune cells.Serial combination therapy: is immune modulation in multiple sclerosis enhanced by initial immune suppression?The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations.Observational Study of Switching from Natalizumab to Immunomodulatory Drugs.The heritage of glatiramer acetate and its use in multiple sclerosis
P2860
Q24235498-BA97B206-CC81-41B6-A0B9-AFF81480D31EQ34409536-9DAA6062-A6B9-4DF2-9566-4513906431C8Q37514237-D74AAE63-17F1-4E25-B0BD-8607AE7BCC37Q37729045-793A60BE-59D8-4EBC-9E14-43A419226832Q37732340-C82EB8A8-D9F4-49FD-B2D0-4310CBDAA72AQ37785554-D75AFDF0-F22E-4B6C-BDF0-37E4494AC492Q37857752-2E1E32E8-E8EE-45FF-9620-BB041211701BQ37997089-8E8FB6C0-789E-4937-916F-58E8CC7B888AQ38152977-C564C10B-6119-42CB-B171-EEEF0DECCED1Q38254152-77F3F5DD-B878-4402-AB1E-AC6966544868Q43295185-0A21AF3C-B859-4D8E-A1CB-ABB9A7BB2921Q45066717-699BC247-718D-46F7-ADC9-8CB6907E041FQ51218322-CFD9E596-127E-4737-B643-90B5BAC71C90Q56804781-9C745B55-3010-43A7-8034-A0C5E2A09441
P2860
Glatiramer acetate after mitoxantrone induction improves MRI markers of lesion volume and permanent tissue injury in MS.
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Glatiramer acetate after mitox ...... permanent tissue injury in MS.
@ast
Glatiramer acetate after mitox ...... permanent tissue injury in MS.
@en
Glatiramer acetate after mitox ...... permanent tissue injury in MS.
@nl
type
label
Glatiramer acetate after mitox ...... permanent tissue injury in MS.
@ast
Glatiramer acetate after mitox ...... permanent tissue injury in MS.
@en
Glatiramer acetate after mitox ...... permanent tissue injury in MS.
@nl
prefLabel
Glatiramer acetate after mitox ...... permanent tissue injury in MS.
@ast
Glatiramer acetate after mitox ...... permanent tissue injury in MS.
@en
Glatiramer acetate after mitox ...... permanent tissue injury in MS.
@nl
P2093
P2860
P1433
P1476
Glatiramer acetate after mitox ...... permanent tissue injury in MS.
@en
P2093
D Campagnolo
D L Arnold
M S Freedman
P2860
P2888
P304
P356
10.1007/S00415-008-0911-X
P577
2008-10-07T00:00:00Z
P6179
1016875544